The impact of migraine on patients with major depressive disorder

被引:35
|
作者
Hung, CI
Liu, CY
Juang, YY
Wang, SJ [1 ]
机构
[1] Natl Yang Ming Univ, Neurol Inst, Taipei Vet Gen Hosp, Sch Med, Taipei, Taiwan
[2] Natl Yang Ming Univ, Dept Neurol, Sch Med, Taipei, Taiwan
[3] Chang Gung Mem Hosp, Dept Psychiat, Taoyuan, Taiwan
[4] Chang Gung Univ, Sch Med, Taoyuan, Taiwan
来源
HEADACHE | 2006年 / 46卷 / 03期
关键词
anxiety; depression; headache; migraine;
D O I
10.1111/j.1526-4610.2006.00378.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background.-The impact of migraine and other headache types among psychiatric outpatients with major depressive disorder (MDD) has not been fully described. Objective.-To investigate the impact of migraine on the severity, physical, and anxiety symptoms in patients with MDD and to examine the interaction between headache and depression. Methods.-This clinic-based study enrolled consecutive psychiatric outpatients meeting DSM-IV criteria for MDD. Headache types were diagnosed based on the International Classification of Headache Disorders, 2nd edition (2004). Three psychometric instruments were used to evaluate anxiety, depression, and physical components: the Hamilton Depression Rating Scale, the Beck Depression Inventory, and the Hospital Anxiety and Depression Scale. In addition, the interactions between headache and their depressive episode were also evaluated. Results.-Compared with patients without migraine, MDD patients with comorbid migraine (n = 73, 48.3%) had higher physical and anxiety scores on the three psychometric instruments. Migraine accounted for 5% to 11% of the variance of the total scores on the three psychometric scales. Approximately half (48.5%) of patients reported headache worsening during or after a depressive episode. Conclusions.-Our study found that comorbidity of migraine in patients with MDD was associated with more anxiety and physical symptoms. Headache should not be considered as only a somatic symptom of depression, but should be treated as an important comorbid disorder because it might exacerbate or interact with depression during a depressive episode.
引用
收藏
页码:469 / 477
页数:9
相关论文
共 50 条
  • [1] The impact of anxiety and migraine on quality of sleep in patients with major depressive disorder
    Hsu, Shih-Chieh
    Wang, Shuu-Jiun
    Liu, Chia-Yih
    Juang, Yeong-Yuh
    Yang, Ching-Hui
    Hung, Ching-I
    [J]. COMPREHENSIVE PSYCHIATRY, 2009, 50 (02) : 151 - 157
  • [2] UNITE: Efficacy and Impact of Fremanezumab in Patients with Migraine and Major Depressive Disorder
    Campos, Verena Ramirez
    Lipton, Richard B.
    Krasenbaum, Lynda J.
    Ning, Xiaoping
    Barbanti, Piero
    Roth-Ben Arie, Zipora
    Galic, Maja
    Denysenko, Lex
    Marmura, Michael
    McAllister, Peter
    Mitsikostas, Dimos
    [J]. CEPHALALGIA, 2023, 43 (1supp) : 64 - 65
  • [3] UNITE: Efficacy and impact of fremanezumab in patients with migraine and major depressive disorder
    Ramirez Campos, V.
    Lipton, R. B.
    Krasenbaum, L. J.
    Ning, X.
    Barbanti, P.
    Roth-Ben Arie, Z.
    Galic, M.
    Denysenko, L.
    Marmura, M.
    McAllister, P.
    Mitsikostas, D. D.
    [J]. JOURNAL OF HEADACHE AND PAIN, 2024, 25
  • [4] The impact of anxiety comorbidities and migraine on the sleep quality among patients with major depressive disorder
    Hsu, S.
    Hung, C.
    Wang, S.
    Liu, C.
    Juang, Y.
    Yang, C.
    [J]. SLEEP, 2008, 31 : A319 - A319
  • [5] Migraine symptomatology and major depressive disorder
    Ligthart, Lannie
    Penninx, Brenda W. J. H.
    Nyholt, Dale R.
    Distel, Marijn A.
    de Geus, Eco J. C.
    Willemsen, Gonneke
    Smit, Johannes H.
    Boomsma, Dorret I.
    [J]. CEPHALALGIA, 2010, 30 (09) : 1073 - 1081
  • [6] Impact of fremanezumab treatment on disability outcomes in patients with migraine and major depressive disorder: results of the UNITE study
    McAllister, P.
    Ramirez, Campos, V
    Roth-Ben, Arie Z.
    Krasenbaum, L.
    Ning, X.
    Galic, M.
    Mitsikostas, D.
    [J]. HEADACHE, 2023, 63 : 142 - 142
  • [7] Negative impact of migraine on quality of life after 4 weeks of treatment in patients with major depressive disorder
    Hung, Ching-I
    Liu, Chia-Yih
    Yang, Ching-Hui
    Wang, Shuu-Jiun
    [J]. PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2012, 66 (01) : 8 - 16
  • [8] Impact of fremanezumab treatment on disability outcomes in patients with migraine and major depressive disorder: Results of the UNITE study
    Mcallister, Peter
    Campos, Verena Ramirez
    Roth-Ben Arie, Zipora
    Krasenbaum, Lynda
    Ning, Xiaoping
    Galic, Maja
    Mitsikostas, Dimos
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 455
  • [9] The comorbidity of major depressive disorder, dysthymic disorder and anxiety disorders with migraine
    Cardona-Castrillon, G. P.
    Isaza, R.
    Zapata-Soto, A. P.
    Franco, J. G.
    Gonzalez-Berrio, C.
    Tamayo-Diaz, C. P.
    [J]. REVISTA DE NEUROLOGIA, 2007, 45 (05) : 272 - 275
  • [10] Migraine Predicts Self-Reported Muscle Tension in Patients With Major Depressive Disorder
    Hung, Ching-I
    Liu, Chia-Yih
    Chen, Jane-Jane
    Wang, Shuu-Jiun
    [J]. PSYCHOSOMATICS, 2008, 49 (06) : 502 - 510